Yes, that’s true but the US side JNJ results allowed a pretty clean comparison before the variants were a big factor here, unlike comparing their UK numbers to older trials before the variants had arisen. See my posts here where I looked into those details. It was 70-75% for JNJ efficacy vs 90-95% for the mRNA ones against the Wuhan Classic. Both expected to be lower of course vs new ones, but it’s looking like the higher ones are still higher against those (ie both maybe -10% vs UK strain).